EUVIMEDEUVIMED entdecken
Kommentar

ApoB and Resilient Cost-Effectiveness of Statin Intensity

Ankur Pandya, Jinyi Zhu

JAMA · 05.05.2026 · 335 (17) · 1485

DOI: 10.1001/jama.2026.3531 ↗

Kurz gefasst

Kommentar in der Zeitschrift JAMA, erschienen am 05.05.2026. Verfasst von Ankur Pandya und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. Die Arbeit nennt 15 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Department of Health Policy, Vanderbilt University School of Medicine, Nashville, Tennessee.

Zitieren

APA

Pandya, A., & Zhu, J. (2026). ApoB and Resilient Cost-Effectiveness of Statin Intensity. JAMA, 335(17), 1485. https://doi.org/10.1001/jama.2026.3531

Vancouver

Pandya A, Zhu J. ApoB and Resilient Cost-Effectiveness of Statin Intensity. JAMA. 2026;335(17):1485. doi:10.1001/jama.2026.3531

BibTeX
@article{Pandya2026,
  author = {Pandya, Ankur and Zhu, Jinyi},
  title = {ApoB and Resilient Cost-Effectiveness of Statin Intensity},
  journal = {JAMA},
  year = {2026},
  volume = {335},
  number = {17},
  pages = {1485},
  doi = {10.1001/jama.2026.3531}
}
Kostenlos starten →